← Leaderboards
Valery A Petrenko
Auburn University At Auburn
$4,034,104
Attributed
$4,034,104
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $714.7K · FY2007–14$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$4,034,104 · 3
By mechanism
R01$1,929,255 · 1
U54$1,524,849 · 1
R21$580,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Auburn University At Auburn
Same institution · by research overlap
- Joseph S Janicki$5,829,990
- Elizabeth A Lipke$1,113,267
- Michael W Greene$1,113,267
- Panagiotis Mistriotis$1,742,252
- Douglas R Martin$3,447,411
Others in their field
Top investigators on “Novel Strategies”
- Judith S. Currier · University Of California Los Angeles$321,300,358
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$303,952,589
- Richard A Gibbs · Baylor College Of Medicine$295,698,028
- Constance Ann Benson · University Of California, San Diego$278,253,569
- Dennis R. Burton · Scripps Research Institute$256,423,824
Research focus
Novel StrategiesNanoparticleLipid BilayersNeoplastic CellMalignant NeoplasmsNanocarrierCytotoxicityDoxorubicinIn VivoLigandsLiposomesBacteriophagesMindBinding (Molecular Function)AntibodiesAffinityAntineoplastic AgentsCancer CellEncapsulatedIn VitroLibrariesCellsChimeric ProteinsPaclitaxel
Grant awards (12)
Develop and High-Throughput Screening of Targeted Anticancer Nanomedicines$294,427
U54 · FY2014 · CA · contact PI
Develop and High-Throughput Screening of Targeted Anticancer Nanomedicines$288,318
U54 · FY2013 · CA · contact PI
Develop and High-Throughput Screening of Targeted Anticancer Nanomedicines$313,331
U54 · FY2012 · CA · contact PI
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins$375,520
R01 · FY2011 · CA · contact PI
Develop and High-Throughput Screening of Targeted Anticancer Nanomedicines$301,572
U54 · FY2011 · CA · contact PI
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins$387,477
R01 · FY2010 · CA · contact PI
Develop and High-Throughput Screening of Targeted Anticancer Nanomedicines$327,201
U54 · FY2010 · CA · contact PI
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins$380,792
R01 · FY2009 · CA · contact PI
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins$373,539
R01 · FY2008 · CA · contact PI
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins$411,927
R01 · FY2007 · CA · contact PI
Phage Binding for Continuous Anthrax Spore Detection$290,000
R21 · FY2004 · AI
Phage Binding for Continuous Anthrax Spore Detection$290,000
R21 · FY2003 · AI